Oncology & Cancer

EU approves treatment for prostate cancer

The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.

Obstetrics & gynaecology

Preclinical study identifies new target for recurrent ovarian cancer

Despite recent advances, ovarian cancer remains the fifth leading cause of cancer-related deaths among women, and there's a critical need for new treatment options, especially for advanced cancers that grow back after standard ...

Medications

Drug combination shows potential in aggressive leukemia

Acute myeloid leukemia (AML) is an aggressive form of cancer that originates in the bone marrow, rapidly spreads to the blood, and can quickly cause death if not treated promptly. Despite recent therapeutic advances, it continues ...

page 15 from 40